Tether’s Bold Foray into Brain-Computer Interface Technology

Cryptocurrency giant Tether has embarked on an ambitious venture beyond digital finance, investing $200 million to acquire a majority stake in Blackrock Neurotech, a leading brain-computer interface company. This strategic move, executed through Tether’s venture division, Tether Evo, signifies the company’s commitment to advancing neurotechnology and making it accessible to a broader audience.

Blackrock Neurotech, based in the United States, specializes in developing neural implants that enable direct communication between the human brain and computers. These devices have the potential to revolutionize the lives of individuals with neurological disorders by restoring motor functions and facilitating control over digital interfaces. Notably, Blackrock Neurotech has achieved significant milestones, including restoring speech for an ALS patient through a BCI implant, enabling communication at a rate of 62 words per minute.

Paolo Ardoino, Tether’s Chief Technology Officer, emphasized the importance of democratizing access to such transformative technologies. He stated that Tether is committed to developing BrainOS as an open-source platform, collaborating with universities worldwide to ensure the technology remains in the public domain. This approach aims to prevent monopolization by a few entities and promote widespread adoption and innovation in the BCI field.

The development of BrainOS is poised to position Tether as a significant player in the neurotechnology sector, directly competing with companies like Neuralink. Founded by Elon Musk, Neuralink has been at the forefront of BCI innovation, recently implanting its device in a third human patient. This patient, paralyzed from the neck down, has been able to control digital devices through thought, marking a significant advancement in the practical application of BCI technology.